F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement
-
LORENA AGUILAR [1] ; GALIA RAMÍREZ [1] ; CAROLINA VALCK [1] ; MARÍA C MOLINA [1] ; ÁLVARO ROJAS [1] ; WILHELM SCHWAEBLE [2] ; VIVIANA FERREIRA [3] ; ARTURO FERREIRA [1]
-
[1] Universidad de Chile
Universidad de Chile
Santiago, Chile
-
[2] University of Leicester
University of Leicester
GB.ENG.H4.31UC, Reino Unido
-
[3] University of Texas Department of Biochemestry
-
- Localización: Biological Research, ISSN-e 0717-6287, ISSN 0716-9760, Vol. 38, Nº. 2-3, 2005, págs. 187-195
- Idioma: inglés
- Enlaces
-
Resumen
Trypanosoma cruzi calreticulin (TcCRT), described in our laboratory, retains several important functional features from its vertebrate homologues. We have shown that recombinant TcCRT inhibits the human complement system when it binds to the collagenous portion of C1q. The generation of classical pathway convertases and membrane attack complexes is thus strongly inhibited. In most T. cruzi-infected individuals, TcCRT is immunogenic and mediates the generation of specific antibodies. By reverting the C1q / TcCRT interaction, a parasite immune evasion strategy, these antibodies contribute to the host / parasite equilibrium. In an in vitro correlate of this situation, we show that the C1q / TcCRT interaction is inhibited by F(ab')2 polyclonal anti-TcCRT IgG fragments. It is therefore feasible that in infected humans anti-TcCRT antibodies participate in reverting an important parasite strategy aimed at inhibiting the classical complement pathway. Thus, membrane-bound TcCRT interacts with the collagenous portion C1q, and this C1q is recognized by the CD91-bound host cell CRT, thus facilitating parasite internalization. Based on our in vitro results, it could be proposed that the in vivo interaction between TcCRT and vertebrate C1q could be inhibited by F(ab')2 fragments anti-rTcCRT or against its S functional domain, thus interfering with the internalization process
